Continuous production of a hybrid antibiotic by Streptomyces lividans TK21 pellets in a three-phase fluidized-bed bioreactor

M. Sarrà, C. Casas, F. Gòdia

    Research output: Contribution to journalArticleResearchpeer-review

    21 Citations (Scopus)

    Abstract

    The continuous production of a hybrid antibiotic by a transformed strain of Streptomyces lividans TK21 in a three-phase fluidized bed is studied. Cell aggregates, known as pellets, are used as immobilized cell particles in the bioreactor. A methodology to prepare pellets of a suitable size and morphology is developed. The continuous production of the antibiotic is studied on the basis of decoupling cell growth and antibiotic production, by means of phosphate limitation in the growth medium. The best results are achieved at D = 0.021 h1, with alternate feeding of O and 0.05 mM phosphate media. Continuous production of the antibiotic can be maintained at satisfactory levels for periods of 60 days, and stable operation of the bioreactor is achieved during 85 days. Finally, the evolution of the internal structure of the pellets during continuous fermentation is studied.
    Original languageEnglish
    Pages (from-to)601-610
    JournalBiotechnology and Bioengineering
    Volume53
    Issue number6
    DOIs
    Publication statusPublished - 20 Mar 1997

    Keywords

    • continuous fermentation
    • fluidized bed
    • hybrid antibiotic
    • immobilized cells
    • morphology
    • pellet
    • Streptomyces

    Fingerprint Dive into the research topics of 'Continuous production of a hybrid antibiotic by Streptomyces lividans TK21 pellets in a three-phase fluidized-bed bioreactor'. Together they form a unique fingerprint.

    Cite this